Remus Pharmaceuticals Limited — Insider Trade, 23-12-2025: Insider Trading
23-12-2025 | 03:28 pm
23-12-2025 | 03:28 pm
Renosen Pharmaceuticals Private Limited (Promoter) has bought 500 shares of Remus Pharmaceuticals Limited, valued at ₹375790, on Fri Dec 19 2025 through Market Purchase. Previously, the holding was 108000 shares, which has now changed to 108500 shares, resulting in a total shareholding of 0.92% in Remus Pharmaceuticals Limited.
No comments yet. Be the first to comment!
